D-0413-2019 Class II

Recalled by Prinston Pharmaceutical Inc — Somerset, NJ

Recall Details

Product Type
Drugs
Report Date
February 6, 2019
Initiation Date
January 18, 2019
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
87505 bottles

Product Description

Irbesartan and Hydrochlorothiazide Tablets, USP 150/12.5 mg Rx 30 Tablets Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 NDC 43547-330-03

Reason for Recall

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Distribution Pattern

Nationwide

Code Information

325D18004 325D18005